ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

Robust operating profit and record level of funds for grants
18. April 2018
The Lundbeck Foundation enters partnership with BrainFacts.org
10. April 2018
Four neuroscientists receive The Brain Prize for crucial research on Alzheimer’s
6. March 2018